Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography
- PMID: 15094752
- DOI: 10.1038/sj.bmt.1704523
Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography
Abstract
We treated three patients with steroid-refractory acute graft-versus-host disease (aGVHD) with intra-arterial steroid-injection therapy (IAST). Two patients with gut aGVHD received IAST into both superior and inferior mesenteric arteries, while one patient with liver aGVHD received IAST into the proper hepatic artery. The volume of stools and the bilirubin level improved soon after IAST. Angiography of the superior and inferior mesenteric arteries was performed in the two patients with steroid-refractory gut aGVHD, and identical abnormal findings were obtained. IAST might be an earlier option for steroid-refractory aGVHD.
Similar articles
-
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.Am J Hematol. 2007 Jan;82(1):45-52. doi: 10.1002/ajh.20752. Am J Hematol. 2007. PMID: 16937391 Clinical Trial.
-
Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.Bone Marrow Transplant. 2001 Jul;28(1):47-9. doi: 10.1038/sj.bmt.1703094. Bone Marrow Transplant. 2001. PMID: 11498743
-
Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin.Bone Marrow Transplant. 2001 May;27(10):1059-64. doi: 10.1038/sj.bmt.1703032. Bone Marrow Transplant. 2001. PMID: 11438821
-
Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.PLoS One. 2015 Aug 31;10(8):e0136991. doi: 10.1371/journal.pone.0136991. eCollection 2015. PLoS One. 2015. PMID: 26323092 Free PMC article.
-
Clinical utility of rituximab in chronic graft-versus-host disease.Ann Pharmacother. 2009 Feb;43(2):316-21. doi: 10.1345/aph.1L386. Epub 2009 Feb 3. Ann Pharmacother. 2009. PMID: 19193571 Review.
Cited by
-
Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD.Bone Marrow Transplant. 2017 Oct;52(10):1416-1422. doi: 10.1038/bmt.2017.120. Epub 2017 Jun 26. Bone Marrow Transplant. 2017. PMID: 28650453 Clinical Trial.
-
Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease.Turk J Haematol. 2012 Dec;29(4):409-12. doi: 10.5505/tjh.2012.57855. Epub 2012 Dec 5. Turk J Haematol. 2012. PMID: 24385731 Free PMC article.
-
Intra-mesenteric steroids for steroid-refractory graft-versus-host disease in pediatric patients: A safe option.Biomedica. 2024 Dec 23;44(Sp. 2):63-71. doi: 10.7705/biomedica.7394. Biomedica. 2024. PMID: 39836853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical